Trial Phase
Trial Status
Paid Participation
Clear All
15 Dementia Trials near San Antonio, TX
Power is an online platform that helps thousands of Dementia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Donepezil for Dementia
San Antonio, TexasKey Eligibility Criteria
AVP-786 for Agitation in Alzheimer's Disease
San Antonio, TexasAL001 for Frontotemporal Dementia
San Antonio, TexasRACS App for Cognitive Impairment
San Antonio, TexasSensory Stimulation for Alzheimer's Disease
San Antonio, TexasDonanemab for Early Alzheimer's Disease
San Antonio, TexasEscitalopram for Agitation in Alzheimer's Disease
San Antonio, TexasAntipsychotics for Lewy Body Disease
San Antonio, TexasKey Eligibility Criteria
AL001 for Frontotemporal Dementia
San Antonio, TexasAtorvastatin for Preventing Dementia
San Antonio, TexasKey Eligibility Criteria
Sensory Stimulation for Alzheimer's Disease
San Antonio, TexasKey Eligibility Criteria
Zoledronic Acid for Parkinson's Disease
San Antonio, TexasRemternetug for Alzheimer's Disease
Shavano Park, TexasACI-24.060 for Alzheimer's Disease and Down Syndrome
San Antonio, TexasKey Eligibility Criteria
LOCK Sleep Program for Dementia
San Marcos, TexasKey Eligibility Criteria
Frequently Asked Questions
How much do Dementia clinical trials in San Antonio, TX pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Dementia clinical trials in San Antonio, TX work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Dementia trials in San Antonio, TX 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in San Antonio, TX for Dementia is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in San Antonio, TX several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Dementia medical study in San Antonio, TX ?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Dementia clinical trials in San Antonio, TX ?
Most recently, we added RACS App for Cognitive Impairment, Donepezil for Dementia and Sensory Stimulation for Alzheimer's Disease to the Power online platform.